- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Impaired Glucose Tolerance in South Africa
Total 900 results
-
TakedaCompletedType 2 Diabetes MellitusUnited States, Australia, Brazil, Bulgaria, Chile, Croatia, Estonia, Guatemala, India, Israel, Latvia, Mexico, New Zealand, Peru, Romania, Russian Federation, Serbia, South Africa, Ukraine
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Canada, Estonia, France, Georgia, Germany, Guatemala, Italy, Latvia, Lithuania, Mexico, New Zealand, Poland, Russian Federation, South Africa, Spain, Ukraine
-
Eli Lilly and CompanyTerminatedDiabetes Mellitus, Type 2Russian Federation, Spain, Germany, Australia, Austria, Israel, Czech Republic
-
Metabolic Solutions Development CompanyCompleted
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Puerto Rico, Russian Federation, Canada, Denmark, India, Poland, Korea, Republic of, Brazil, Argentina, Mexico, South Africa
-
TakedaCompletedType 2 DiabetesUnited States, Poland, United Kingdom, Germany, South Africa, Finland, Estonia, Slovakia, Czech Republic
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Peru, Mexico, Colombia, Costa Rica
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Mexico, Israel, Taiwan, Malaysia, Hungary, Turkey, Morocco, Germany, South Africa, Portugal, Lebanon, Italy, Brazil, Croatia, Egypt, Spain, Russian Federation, Greece, Argentina, Korea, Republic of, Poland, Serbia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Argentina, Turkey, Canada, South Africa, Mexico
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Sweden, Norway, Germany, Australia
-
AstraZenecaCompletedType 2 DiabetesMexico, United States, Poland, Canada, Russian Federation, South Africa, France, Hungary, India, United Kingdom
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, New Zealand, Spain, Japan, Finland, Germany, Greece, Romania, South Africa, Denmark, Colombia, Poland, United Kingdom, Mexico, Australia, Belgium, Ireland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Israel, Puerto Rico, Slovakia, Canada, South Africa, United Kingdom, Czech Republic
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, France, United Kingdom, Russian Federation, Germany, South Africa
-
PerspectumKing's College Hospital NHS Trust; University of Coimbra; Liverpool University... and other collaboratorsCompletedMetabolic Syndrome | NAFLD | NASH - Nonalcoholic SteatohepatitisUnited Kingdom, Germany, Netherlands, Portugal
-
ResMedRoyal North Shore Hospital; International Diabetes Center at Park Nicollet; Baker...CompletedDiabetes Mellitus Type 2United States, Australia, Canada
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2India, United States, Thailand, Japan, Germany, Turkey, Hungary, Malaysia, Poland, South Africa, Czechia, Italy, France, Slovenia
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesSweden, France, Italy, Mexico, South Africa, Spain, Germany, Netherlands, Argentina, United Kingdom
-
Provention Bio, a Sanofi CompanyRecruitingDiabetes Mellitus, Type 1United States
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2France, Poland, United Kingdom, United States, Spain, Colombia, India, Romania, South Africa, Ukraine, Australia, Canada, Greece, Sweden, New Zealand, Switzerland, Hong Kong
-
Wyeth is now a wholly owned subsidiary of PfizerTerminatedDiabetes MellitusChina, United States, Canada, Mexico, Russian Federation, Croatia, United Kingdom, Argentina, Australia, India, South Africa, Greece, Ukraine, Romania, Italy, Hong Kong, Former Serbia and Montenegro, Brazil
-
AstraZenecaCompletedDiabetesKorea, Republic of, Mexico, Taiwan, United States, Argentina, Brazil, Puerto Rico, South Africa, Hong Kong, Israel, Singapore, Peru, Philippines
-
Gilead SciencesCompletedType 2 Diabetes MellitusUnited States, Russian Federation, Thailand, Serbia, Poland, Hungary, Malaysia, South Africa, Ukraine, Czech Republic, Romania, Slovakia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United Kingdom
-
SanofiCompletedType 2 DiabetesUnited States, Australia, Bulgaria, Canada, Denmark, Germany, Norway, Peru, Poland, South Africa, Spain, Sweden, United Kingdom
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1United Kingdom, United States, Australia, Canada, Poland, Denmark, Spain, Croatia, Sweden, Greece, Belgium, France, New Zealand, South Africa, Israel, Brazil, Ireland, Netherlands, Lithuania, Slovakia
-
SanofiCompletedType 1 Diabetes MellitusUnited States, Austria, Brazil, Chile, Czech Republic, Germany, Hungary, India, Mexico, Peru, Poland, Romania, Russian Federation, South Africa, Spain, Turkey
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusItaly, Korea, Republic of, Hungary, Canada, Australia
-
National Institute of Diabetes and Digestive and...Juvenile Diabetes Research FoundationTerminatedType1 Diabetes MellitusUnited States, Australia, Italy, United Kingdom, Sweden, Canada
-
GlaxoSmithKlineCompletedMetabolic Syndrome XSpain, Argentina, Australia, Latvia, India, Mexico, Pakistan, Slovakia, Costa Rica, New Zealand, Romania, Russian Federation, Chile
-
Eli Lilly and CompanyAlkermes, Inc.CompletedDiabetes Mellitus, Type 2United States, Germany, Puerto Rico, United Kingdom, Spain, Canada, Brazil, Korea, Republic of, India, Israel, Russian Federation, South Africa
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Poland, United States, Japan, Korea, Republic of, Germany, Bulgaria, South Africa, Portugal, Ukraine
-
Ritter Pharmaceuticals, Inc.CompletedLactose IntoleranceUnited States
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Puerto Rico, Poland, Canada, Austria, Mexico, Denmark, Croatia, Brazil, Argentina, Romania, South Africa, Russian Federation, France, Lithuania
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, Croatia, Japan, Slovakia, Germany, Latvia, South Africa, Czechia, United Arab Emirates, Hungary, Ukraine, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesMalaysia, Australia, Taiwan, Thailand, Hong Kong, Singapore, Philippines
-
Duke UniversityEli Lilly and Company; Boehringer IngelheimActive, not recruitingCardiovascular Diseases | Diabetes Mellitus, Type 2United States
-
Bristol-Myers SquibbCompletedDiabetes Mellitus, Type 2Canada, Australia, United States
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2United States, Estonia, Latvia, Mexico
-
University of MinnesotaMedical University of South Carolina; Johns Hopkins University; National Institute... and other collaboratorsActive, not recruitingPancreatitis | Pancreatectomy; Hyperglycemia | Pancreatitis, ChronicUnited States
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2 | Chronic Kidney DiseaseSpain, United States, Italy, Denmark, Poland, South Africa, Canada, France
-
Gilead SciencesCompletedType 2 Diabetes MellitusUnited States, Russian Federation, Serbia, Poland, Hungary, South Africa, Ukraine, Romania, Slovakia, Czech Republic
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Germany, Lithuania
-
AstraZenecaTerminatedType 2 DiabetesFrance, Korea, Republic of, South Africa, Spain, United Kingdom, Vietnam, Norway, Israel, Philippines, Australia
-
TakedaCompletedDiabetes MellitusUnited States, Poland, Germany, Argentina, South Africa, Netherlands, Peru, Czech Republic, Brazil, Chile, Guatemala, Dominican Republic
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2United States
-
PfizerCompletedDiabetes Mellitus, Type IIUnited States
-
AstraZenecaEli Lilly and CompanyCompleted
-
N-Gene Research Laboratories, Inc.Thermo Fisher Scientific, Inc; Integrium; Msource Medical Development GmbH; Kinexum... and other collaboratorsTerminatedDiabetes MellitusUnited States, Germany, Hungary
-
vTv TherapeuticsCompleted